Stem-cell work wins big award for pair
by Sheryl Ubelacker
Canadian Press
September 19, 2005
TORONTO -- On the surface, at least, they seem an unlikely duo: one, the offspring
of a Toronto physician, educated at Ontario's tony Upper Canada
College; the other, the son of a Saskatchewan farmer, who attended
local public high school. Ernest McCulloch followed his father into
medicine; James Till veered sharply from his roots to become a biophysicist.
But what the two men share is a passionate devotion to science
-- and their serendipitous pairing led to a discovery that laid
the foundation for what may be the most promising and ethically
controversial area of international medical research today.
That discovery was recognizing the first stem cell, an entity that
had been theorized about since the early 1900s, but never found
until Dr. McCulloch and Dr. Till made the intellectual leap in the
early 1960s while experimenting with bone marrow in laboratory mice.
Dubbed the fathers of stem-cell research, the long-term colleagues
will be honoured Friday in New York with the 2005 Lasker Award for
basic medical research, sharing a prize of $50,000 (U.S.). The Laskers,
referred to as "America's Nobels," have often been prescient:
70 of its winners have gone on to win Nobel prizes, 19 in the last
15 years.
The Lasker is the latest in a long list of honours for Dr. Till
and Dr. McCulloch, including being named Officers of the Order of
Canada and inducted into the Medical Hall of Fame.
But true to their belief in scientific integrity, and in perhaps
typically Canadian fashion, they steadfastly refuse to overstate
their contribution to medical history.
"It's a surprise and a thrill," Dr. McCulloch, 79, said
of the award during an interview with Dr. Till at Princess Margaret
Hospital in Toronto, where they remain semi-retired senior scientists
at the centre's Ontario Cancer Institute.
"After 40 years, I think it means our work has stood the test
of time reasonably well," added Dr. Till, 74.
As with many great partnerships, their pairing came about more by
accident than design.
Dr. McCulloch wanted to investigate how injected bone marrow would
affect lab mice that had undergone lethal doses of radiation.
"And Dr. [Harold] Johns wasn't going to allow any mere physician
to have anything to do with his radiation devices," Dr. McCulloch
said of the Canadian who invented the Cobalt-60 radiation machine
to treat cancer.
"He asked for volunteers to do the radiation of the mice, and
Dr. Till volunteered. And once we began working together, it was
no longer Dr. Till doing radiation and me doing bone-marrow function.
We were both doing everything and have been doing everything together
really ever since, although in different ways."
During one experiment, they discovered lumps of cells scattered
over the animals' spleens -- the number of which exactly matched
the number of marrow cells they had injected.
What was born from that eureka moment 45 years ago was a shift in
emphasis from trying to "see" stem cells, which are rare
(maybe one in 1,000 cells) and by microscope look much like any
other cell.
"We had switched the focus from what might they look like to
what can they do," Dr. Till said. "That was, I believe,
our major contribution, to say: 'Forget it. Who cares whether they're
purple or not. Let's focus on what they can do.' "
Today, stem cells from blood, tissue and embryos are seen as the
great hope of medicine, whether as the key to understanding how
to defeat many cancers to regenerating disease-ravaged organs like
hearts and livers and even parts of the brain.
|